Latest Article
![Mutual benefit Patient centricity in clinical trials Mutual benefit Patient centricity in clinical trials](/sites/default/files/2023-09/Mutual%20benefit%20Patient%20centricity%20in%20clinical%20trials.jpg)
Mutual benefit: Patient centricity in clinical trials
Uli Broedl (Corp. SVP, Head of Global Clinical Development & Operations) and Bronwyn Lewis (Global Head of Patient Engagement) share their learnings from successfully collaborating with patient organizations on clinical trial design
Links
![Lunsayil 1 Clinical Trial Lunsayil 1 Clinical Trial](/sites/default/files/2023-09/Lunsayil%201%20Clinical%20Trial.jpg)
Lunsayil 1 Clinical Trial
A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa.
Downloads
![Hidradenitis Suppurativa Hidradenitis Suppurativa](/sites/default/files/2023-09/Hidradenitis%20Suppurativa.jpg)
What is Hidradenitis Suppurativa (HS)?
Related Content
![Skin Diseases Skin Diseases](/sites/default/files/2023-09/Skin%20Diseases.jpg)
Immunology
Skin Diseases
Boehringer Ingelheim’s focus on advancing treatments for skin diseases
![Mutual benefit Patient centricity in clinical trials Mutual benefit Patient centricity in clinical trials](/sites/default/files/2023-09/Mutual%20benefit%20Patient%20centricity%20in%20clinical%20trials.jpg)
Patient centricity
Mutual benefit: Patient centricity in clinical trials
Uli Broedl (Corp. SVP, Head of Global Clinical Development & Operations) and Bronwyn Lewis (Global Head of Patient Engagement) share their learnings from successfully collaborating with patient organizations on clinical trial design.